Skip to content

← All news

Markets

Actuate Therapeutics stock gets FDA clearance for elraglusib trial

1 source ·1 article ·Aug 18, 11:32 UTC Actuate Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com Canada ·Aug 18, 11:32 UTC

Actuate Therapeutics stock gets FDA clearance for elraglusib trial